Current price is more than the intrinsic value

Intrinsic Value

Stock has not been able to generate better return on equity than bank FD

Returns vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Indoco Remedies receives revision in credit ratings

Indoco Remedies Ltd witnessed volume of 51.61 lakh shares by 14:19 IST on NSE, a 26.58 times surge over two-week average daily volume of 1.94 lakh shares

Volumes jump at Indoco Remedies Ltd counter

Shares of Auro Laboratories and Indoco Remedies rallied 20 per cent each to Rs 194.15 and 482.95, respectively. Vineet Labs soared 10 per cent to 81.75 on Friday. All three companies hit their respective upper circuit limits.

What sparked a rally in small pharma stocks today

Indoco Remedies Ltd, Pricol Ltd, CARE Ratings Ltd and Jain Irrigation Systems Ltd are among the other gainers in the BSE’s ‘A’ group today, 02 July 2021.

Mangalam Cement Ltd leads gainers in ‘A’ group

The Nifty Realty index gained 0.69% at 345.15 amid buying interest witnessed seen in Oberoi Realty, Brigade, DLF, Phoenix, Prestige and Godrej Properties which was up 2-1% respectively.

Nifty holds over 15,700; Realty stocks in demand; Route Mobile, Indoco Remedies outperform

Indoco Remedies Management Meet Update: Nirmal Bang

Indoco Remedies Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 3654.22 Crore) operating in Pharmaceuticals sector.

Buy Indoco Remedies, target price Rs 430: Yes Securities

ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 390 in its research report dated May 26, 2021.

Buy Indoco Remedies; Target Of Rs 390: ICICI Direct

The company’s export formulations grew 65.6 per cent YoY to Rs 132 crore, driven by strong growth in regulated and emerging markets

Indoco Remedies zooms 20% on strong revenue from international business

The Managing Director of Indoco Remedies, Aditi Kare Panandikar, lays out a fine print of the Q4 numbers and the guidance for going forward. Although the company's US business was down around 27% on a q-o-q basis, she says that it has been a huge revival this year as their international business grew by 66% and US business is also up 23.5% on a y-o-y basis.

#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #AditiKarePanandikar #IndocoRemedies

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Indoco Remedies MD Aditi Kare Panandikar On Their Biz In Q4 | Halftime Report | CNBC-TV18

Indoco Remedies Q4 Review - Covid-19 Impacts FY21; Outlook Remains Strong: Prabhudas Lilladher

Indoco Remedies Limited is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).

Indoco Remedies Ltd

Indoco Remedies Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Indoco Remedies receives revision in credit ratings

Volumes jump at Indoco Remedies Ltd counter

What sparked a rally in small pharma stocks today

Mangalam Cement Ltd leads gainers in ‘A’ group

Nifty holds over 15,700; Realty stocks in demand; Route Mobile, Indoco Remedies outperform

Indoco Remedies Management Meet Update: Nirmal Bang

Buy Indoco Remedies, target price Rs 430: Yes Securities

Indoco Remedies Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Indoco Remedies receives revision in credit ratings

Volumes jump at Indoco Remedies Ltd counter

What sparked a rally in small pharma stocks today

Mangalam Cement Ltd leads gainers in ‘A’ group

Nifty holds over 15,700; Realty stocks in demand; Route Mobile, Indoco Remedies outperform

Indoco Remedies Management Meet Update: Nirmal Bang

Buy Indoco Remedies, target price Rs 430: Yes Securities

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock